The China Food and Drug Administration has approved Eye Tech Care’s EyeOP1 glaucoma treatment product, according to a company press release.
EyeOP1 treats glaucoma with high-intensity focused ultrasound technology and is the first noninvasive medical device approved for glaucoma treatment in China, the release said.
The procedure takes less than 3 minutes and has a short learning curve.
“We are convinced that our technology will bring high value to the glaucoma market in China and provide new treatment options to patients,” Dietrich Wolf, PhD, Eye Tech Care CEO, said in the
Uncategorized